Moderna (Brazil) Investor Sentiment

M1RN34 Stock  BRL 12.10  0.05  0.41%   
About 62% of Moderna's investor base is looking to short. The analysis of current outlook of investing in Moderna suggests that many traders are alarmed regarding Moderna's prospects. The current market sentiment, together with Moderna's historical and current headlines, can help investors time the market. In addition, many technical investors use Moderna stock news signals to limit their universe of possible portfolio assets.
  
over a week ago at news.google.com         
Moderna reinstated with an Underperform at BofA - Yahoo Finance
Google News at Macroaxis
over a week ago at news.google.com         
BofA downgrades Moderna, says its tough time to be vaccine maker - Yahoo Finance
Google News at Macroaxis
over a month ago at news.google.com         
Goldman Sachs Moderna, Inc. Is A Top Growth Investor Stock - Yahoo Finance
Google News at Macroaxis
over a month ago at news.google.com         
Is Investing in Moderna Stock Simply Dead Money - TipRanks
Google News at Macroaxis
over a month ago at news.google.com         
HSBC upgrades Moderna to Buy on pipeline potential - Yahoo Finance
Google News at Macroaxis
over a month ago at news.google.com         
Why Pfizer, Moderna, Other Vaccine Stocks Are Taking A Beating - Investors Business Daily
Google News at Macroaxis
over two months ago at news.google.com         
Moderna Rises Higher Than Market Key Facts - Yahoo Finance
Google News at Macroaxis
over two months ago at news.google.com         
Moderna Inc Jim Cramer Is Disappointed - Yahoo Finance
Google News at Macroaxis
over three months ago at news.google.com         
Modernas Pain Continues Amid Flurry Of Downgrades Following Tough RD Day - Investors Business Daily
Google News at Macroaxis
over three months ago at news.google.com         
Moderna Stock Drops on Plans To Cut 1.1B in RD Costs - Investopedia
Google News at Macroaxis
over three months ago at news.google.com         
Shareholders have faith in loss-making Moderna as stock climbs 6.8 percent in past week, taking five...
Google News at Macroaxis
over three months ago at news.google.com         
Moderna EU COVID-19 vaccine sales slashed as Ukraine war strains budgets, US remains strong market C...
Google News at Macroaxis
over three months ago at news.google.com         
Moderna State Of Play Ahead Of Q2 Earnings, Im Pessimistic - Seeking Alpha
Google News at Macroaxis
over three months ago at news.google.com         
Moderna Insiders Sell US3.3m Of Stock, Possibly Signalling Caution - Yahoo Finance
Google News at Macroaxis
over three months ago at news.google.com         
Down 60 percent in 3 Years, Will Moderna Stock Fall Further - TipRanks
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Moderna that are available to investors today. That information is available publicly through Moderna media outlets and privately through word of mouth or via Moderna internal channels. However, regardless of the origin, that massive amount of Moderna data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Moderna news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Moderna relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Moderna's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Moderna alpha.

Moderna Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Moderna Stock analysis

When running Moderna's price analysis, check to measure Moderna's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moderna is operating at the current time. Most of Moderna's value examination focuses on studying past and present price action to predict the probability of Moderna's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Moderna's price. Additionally, you may evaluate how the addition of Moderna to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device